10.03  0 (0%)		12-05 12:41
Open: 10.03 High: 10.0301 Volume: 300		Pre. Close: 10.03 Low: 10.03 Market Cap: 0(M)

Short term
Mid term
Targets	6-month :	11.56	1-year :	13.5
Resists	First :	9.89	Second :	11.56
Pivot price	9.86
Supports	First :	9.84	Second :	9.81
MAs	MA(5) :	9.87	MA(20) :	9.86
	MA(100) :	9.84	MA(250) :	9.92
MACD	MACD :	0	Signal :	0
%K %D	K(14,3) :	70.3	D(3) :	71.8
RSI	RSI(14): 52.6
52-week	High :	10.4	Low :	9.77

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ REVHU ] has closed below upper band by 45.3%. Bollinger Bands are 29.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	9.87 - 9.92	9.92 - 9.97
Low:	9.74 - 9.79	9.79 - 9.85
Close:	9.79 - 9.87	9.87 - 9.95

Revolution Healthcare Acquisition Corp. does not have significant operations. The company intends to acquire assets and businesses through a merger, share exchange, share purchase, reorganization, or similar business combination. It focuses on pursuing opportunities in health care, life sciences, and technology industries. The company was incorporated in 2021 and is based in Cambridge, Massachusetts.

Thu, 05 Oct 2023
The unraveling of EQRx's low-cost drug dream - Fierce Biotech

Wed, 04 Oct 2023
How Revolution Medicines chased down EQRx's $1 billion cash prize - San Francisco Business Times - The Business Journals

Thu, 14 Sep 2023
Carbon Revolution Announces Completion of SEC Review and Scheduling of Twin Ridge Shareholder Meeting - Business Wire

Tue, 01 Aug 2023
Revolution Medicines, Inc. to Acquire EQRx, Inc. in All-Stock Transaction to Gain More Than $1 Billion in Additional ... - GlobeNewswire

Tue, 01 Aug 2023
EQRx’s Affordable Drugs Strategy Ends in Acquisition by Revolution, Interested Only in Its Cash - MedCity News

Wed, 28 Jun 2023
Fresenius Moves More than 130 SAP Systems to the Cloud with Rise with SAP - SAP News

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Outperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Financial Services
Industry: Shell Companies
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	31.5 (%)
Shares Short	0 (K)
Shares Short P.Month	6 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-0.63
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	-15.92
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.